Healthline: People are taking high doses of melatonin to sleep: Why experts are concerned
UC expert says taking too much melatonin could disrupt our sleep-wake cycle
According to a research letter published in the Journal of the American Medical Association, more people are taking supplemental melatonin, and at increasingly high doses. Researchers point out these findings raise safety concerns since the actual dose of melatonin supplements could be nearly 500% higher than the label indicates. In a story published by Healthline, Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine was one of the experts cited reacting to the letter.
Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine
“Melatonin is considered a dietary supplement and is not FDA approved for safety or effectiveness,” confirmed Sarah Gallucci, DO, an assistant professor of medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine.
She added that there is an organization that confirms the claimed dosage and purity of some brands.
“Supplements that are verified by the United States Pharmacopeial convention are the most reliable,” said Gallucci. “USP verified supplements are tested to ensure that the potency and amounts match the label and that the product does not contain harmful levels of specified contaminants.”
Gallucci added that melatonin is considered “generally safe,” with few serious adverse effects.
“The most common side effects are headache, dizziness, nausea, and fatigue,” she said.
Gallucci cautioned that taking too much melatonin could disrupt our sleep-wake cycle, making it more difficult to fall asleep.
“Safe starting doses range from 2 to 5 mg,” she advised. “Melatonin does not have any addictive potential, which can be seen with some prescription sleep medications.”
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.